Pharming (PHAR) Net Income - Minority (2019 - 2025)
Historic Net Income - Minority for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to -$264.6 million.
- Pharming's Net Income - Minority fell 1720.7% to -$264.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$264.6 million, marking a year-over-year decrease of 1720.7%. This contributed to the annual value of -$221.1 million for FY2024, which is 104.21% down from last year.
- According to the latest figures from Q3 2025, Pharming's Net Income - Minority is -$264.6 million, which was down 1720.7% from -$239.6 million recorded in Q2 2025.
- In the past 5 years, Pharming's Net Income - Minority registered a high of -$186360.0 during Q1 2021, and its lowest value of -$264.6 million during Q3 2025.
- Over the past 5 years, Pharming's median Net Income - Minority value was -$204.6 million (recorded in 2022), while the average stood at -$179.5 million.
- The largest annual percentage gain for Pharming's Net Income - Minority in the last 5 years was 9989.65% (2022), contrasted with its biggest fall of 10499537.42% (2022).
- Over the past 5 years, Pharming's Net Income - Minority (Quarter) stood at -$194716.5 in 2021, then tumbled by 104995.37% to -$204.6 million in 2022, then decreased by 6.91% to -$218.8 million in 2023, then decreased by 1.04% to -$221.1 million in 2024, then fell by 19.72% to -$264.6 million in 2025.
- Its Net Income - Minority stands at -$264.6 million for Q3 2025, versus -$239.6 million for Q2 2025 and -$214.0 million for Q1 2025.